nucleoside

Related by string. nucleosides * * nucleoside analogues alone . nucleoside analogue . nucleoside analogues . cycle modulating nucleoside . RG# cytosine nucleoside analog . RG# nucleoside analog . non nucleoside reverse . nucleoside phosphorylase PNP . purine nucleoside phosphorylase PNP . nucleoside reverse transcriptase inhibitors . non nucleoside polymerase *

Related by context. All words. (Click for frequent words.) 74 nucleoside analogues 71 nucleoside analogue 71 nucleosides 70 NRTI 68 polymerase inhibitor 68 pharmacokinetic interactions 68 replicon 68 ceftazidime 68 NRTIs 68 nucleoside reverse transcriptase inhibitor 68 pan HDAC inhibitor 67 NNRTIs 67 Bortezomib 67 beta lactam 67 HDACi 67 glycosylated 67 alkylating agent 67 non nucleoside 67 NXL# 66 AEG# 66 AZT zidovudine Retrovir 66 FLT3 66 Voreloxin 66 sodium glucose cotransporter 66 idarubicin 66 interferon IFN 66 Elvitegravir 66 MEK inhibitors 66 epothilone 66 Xanafide 66 NNRTI 66 Symadex 66 polymerase inhibitors 66 BMS # 65 NRTI resistance 65 vinca alkaloid 65 novel immunomodulatory 65 targeting CD# 65 proteasome inhibitor 65 nucleoside analog 65 reverse transcriptase inhibitors 65 cytostatic 65 tigecycline 65 CCR5 antagonist 65 immunomodulatory 65 orally bioavailable 65 nucleoside analogs 65 IFN alpha 65 nucleoside reverse transcriptase inhibitors 65 nucleotide analogs 65 quinolone 65 radezolid 65 pegylated 65 nucleotide analogues 64 humanized antibody 64 PI3K inhibitor 64 Aurora kinase 64 mesylate 64 humanized anti 64 Gleevec resistant 64 subtype selective 64 muscarinic 64 CDK inhibitor 64 endothelin receptor 64 immunomodulation 64 beta lactams 64 d4T stavudine Zerit 64 immunomodulator 64 PDE4 inhibitor 64 topoisomerase 64 Copegus ribavirin 64 MEK inhibitor 64 PSN# [002] 64 pomalidomide 64 T#I [002] 64 c MET 64 molecularly targeted 64 seliciclib 64 proteasome inhibitors 64 IFN α 64 bevacizumab Avastin ® 64 liposomal formulation 64 decitabine 64 protease inhibitor 64 xenograft models 64 selective antagonist 64 celgosivir 64 NS4A 64 echinocandin 64 protease inhibitor PI 64 raltegravir 64 HSP# inhibitor 64 beta lactamase inhibitor 63 ganetespib 63 Raltegravir 63 FGFR 63 anti CD3 63 darunavir 63 CCR5 inhibitor 63 antisense 63 caspofungin 63 Panzem R NCD 63 T#I mutant 63 stavudine d4T 63 peptidic 63 DB# [003] 63 boosted protease inhibitor 63 XmAb# 63 quinoline 63 non nucleoside reverse 63 zidovudine AZT 63 erlotinib Tarceva ® 63 Dasatinib 63 HGS ETR1 63 systemic antifungal 63 cleavable linker 63 thrombin receptor 63 JAK2 inhibitor 63 nucleotide analog 63 BCR ABL inhibitors 63 antisense oligonucleotide 63 Blinatumomab 63 interleukin IL 63 imatinib resistant 63 amprenavir 63 SERMs 63 phosphate S1P 63 Sym# 63 anticancer therapies 63 ara C 63 gemcitabine Gemzar 63 retapamulin 63 oral antiviral 63 GRN#L 63 Hsp# inhibitor 63 IgG1 63 daptomycin 63 rifamycin 63 JAK inhibitor 63 paclitaxel Taxol 63 ganciclovir 63 integrase inhibitor 63 lamivudine 3TC 63 elotuzumab 63 imatinib mesylate 63 Hsp# inhibitors 63 IAP inhibitors 63 EGF receptor 63 oral prodrug 63 synthetic analogues 63 JAK1 63 Aurora Kinase 63 HuLuc# 62 mTOR inhibitors 62 HGS# 62 prostanoid 62 SGLT 2 62 TLR9 agonist 62 Anticalins 62 antisense oligonucleotides 62 multidrug resistance 62 deacetylase inhibitors 62 oncolytic 62 Dapagliflozin 62 MGCD# [001] 62 hypoxia inducible factor 62 Fc fusion protein 62 selective inhibition 62 UGT#A# 62 amphotericin B 62 tenofovir Viread 62 inhibits protein synthesis 62 2 methoxyestradiol 62 PDE4 inhibitors 62 effector function 62 Carfilzomib 62 CCR2 62 chimeric monoclonal antibody 62 imatinib Gleevec ® 62 monoclonal 62 potent inhibition 62 nucleoside nucleotide 62 proteasome inhibitor bortezomib 62 interferon alfa 62 azacytidine 62 Cathepsin S 62 CD# monoclonal antibody 62 microtubule targeting 62 insulin sensitizers 62 pegylated liposomal doxorubicin 62 cytidine 62 echinocandins 62 trabectedin 62 immunotoxin 62 CYP #A# 62 Chemokine Receptor 62 rifamycins 62 Interferon alfa 62 nelfinavir 62 Omacetaxine 62 indinavir 62 antisense compounds 62 immunomodulating 62 enfuvirtide 62 peptide antigens 62 aminoglycoside 62 CYT# potent vascular disrupting 62 V#F mutation 62 cytotoxic 62 dihydrofolate reductase 62 JAK3 62 CD# antibody [001] 62 Tyrima 62 receptor tyrosine kinase inhibitor 62 epigenetic therapies 62 histone deacetylase inhibitor 62 Thiovir 62 Tamibarotene 62 metaglidasen 62 delafloxacin 62 Tumor Necrosis Factor 62 pegylated interferon alpha 62 evaluating tivozanib 62 bexarotene 62 OXi# 62 rilpivirine 62 Cloretazine 62 cytotoxic agents 62 daunorubicin 62 ENMD # 62 alkylating 62 serine protease 62 vascular disrupting agents 62 endothelin receptor antagonists 62 MAb 62 orally administered inhibitor 62 trans retinoic acid 62 PEGylated 62 pertuzumab 62 cidofovir 62 JAK#/JAK# 62 artemisinin derivative 62 Apoptone 62 abacavir Ziagen 62 AP# [003] 62 direct thrombin inhibitors 62 small molecule inhibitors 62 CA4P 62 APTIVUS r 62 Fenretinide 62 chemokine receptor 62 kinase inhibition 62 bispecific 62 nanoviricides 62 ENaC 62 DFMO 62 immune modulating 62 #ME# 62 selective modulator 61 peroxisome proliferator activated 61 pDCs 61 talabostat 61 monomeric 61 VAPRISOL 61 peroxidase 61 IFN beta 61 ALN TTR# 61 Tarvacin 61 tumorigenic 61 vidofludimus 61 parthenolide 61 HBeAg positive 61 #HT#A 61 EndoTAG TM -1 61 CRTH2 61 potent cytotoxic 61 Leukine ® 61 atazanavir Reyataz 61 lanthanum carbonate 61 protein kinase inhibitor 61 small molecule activators 61 tyrosine kinase inhibitor 61 Fibroblast Growth Factor Receptor 61 CRAC channel 61 NS3 protease 61 NEUGENE 61 DCCR 61 Alfacell proprietary ribonuclease 61 antisense drug 61 Sustiva efavirenz 61 pyrimidine 61 elesclomol 61 kinase inhibitors 61 NS5b 61 BCR ABL 61 dimeric 61 familial amyloidotic polyneuropathy FAP 61 histone deacetylase HDAC inhibitors 61 fusion inhibitor 61 HCV protease 61 prodrugs 61 vicriviroc 61 EGFr 61 Hedgehog pathway inhibitor 61 K#N 61 Epothilones 61 highly selective endothelin 61 AKT inhibitor 61 alpha 2a 61 DermaVir 61 isoproterenol 61 receptor inhibitor 61 Preclinical studies suggest 61 lamivudine resistant 61 Gag polymorphisms 61 TTR gene 61 bortezomib 61 siRNA therapeutics 61 mAbs 61 cilengitide 61 CCX# 61 pyrimethamine 61 Vidofludimus 61 synthetic peptides 61 JAK inhibitors 61 vinorelbine 61 colony stimulating factor 61 antimetabolite 61 site directed mutagenesis 61 obatoclax 61 immunostimulatory 61 kinase inhibitor 61 VEGF receptor 61 multitargeted 61 potent inhibitor 61 Nucleoside 61 macrolide antibiotics 61 signal transduction inhibitor 61 humanized monoclonal antibody 61 selective antagonists 61 elvucitabine 61 antitumor 61 Pegylated 61 potent inhibitors 61 lenalidomide dexamethasone 61 pharmacologically active isomer 61 Cloretazine VNP#M 61 nanomolar 61 tenofovir disoproxil fumarate 61 DU #b 61 OMP #M# 61 INCB# [001] 61 Maribavir 61 NS#/#A protease 61 peptide conjugated 61 genotypic resistance 61 benzimidazole 61 AV HALT 61 bortezomib Velcade R 61 CBLC# 61 mimetics 61 L asparaginase 61 IMiDs R 61 dasatinib Sprycel ® 61 clodronate 61 MDV# 61 receptor monoclonal antibody 61 DiLA2 61 Multimeric 61 solithromycin 61 insulin sensitizing 61 microtubule inhibitor 61 recombinant protein 61 HCV replicon 61 pyrimidines 61 isoenzyme 61 nitazoxanide 61 meropenem 61 Survivin 61 PPARgamma 61 geldanamycin 61 nanomolar range 61 lopinavir 61 rhIL 7 61 BAL# [002] 61 cetuximab Erbitux R 61 HCV polymerase inhibitors 61 hTERT 61 transcriptase inhibitor NNRTI 61 receptor antagonists 61 Perifosine 61 pathophysiological effects 61 FK# 61 protein tyrosine phosphatase 61 Pegylated interferon 61 mitochondrial toxicity 61 ELACYT 61 favorable pharmacokinetic profile 61 Cloretazine R 61 racemic 61 Janus kinase 61 PSN# [001] 61 BAY #-# 61 Pathway Inhibitor 61 thrombopoietin 61 TNFa 60 transgene expression 60 genotypic 60 micafungin 60 hENT1 60 indibulin 60 factor HGF 60 CXCR4 60 non nucleoside HCV 60 glycopeptide 60 depsipeptide 60 Valortim ® 60 cholesteryl ester transfer 60 pentamidine 60 corticosteroid dexamethasone 60 KLF4 60 GFT# 60 Vorinostat 60 Seliciclib 60 PRT# 60 pegylated interferons 60 colon carcinoma 60 Aplidin R 60 antitumoral 60 generation antisense inhibitor 60 small molecule Hedgehog 60 beta lactam antibiotics 60 sorafenib Nexavar R 60 Irinotecan 60 VDAs 60 ISIS # 60 protein tyrosine phosphatase 1B 60 thalidomide Thalomid 60 chemotherapeutics 60 antidiabetic 60 PEGylated interferon 60 mitomycin 60 ribonuclease 60 YONDELIS 60 Imatinib 60 covalently linked 60 Mipomersen 60 mRCC 60 antifolates 60 REP# 60 antiangiogenic 60 Darinaparsin 60 TKM ApoB 60 Liposomal 60 Cloretazine ® 60 PREZISTA rtv 60 EGFR tyrosine kinase inhibitors 60 ritonavir boosted 60 PRTX 60 oral JAK1 60 cell lymphoma CTCL 60 Factor VIIa 60 HCV 60 HuMax CD4 60 HCV protease inhibitor 60 immunotherapeutic agent 60 imatinib Gleevec 60 PNP inhibitor 60 histone deacetylase HDAC 60 posaconazole 60 synthetic retinoid 60 taxane 60 CD3 monoclonal antibody 60 S/GSK# 60 CEQ# 60 siRNAs targeting 60 BAL# [001] 60 sphingosine 1 60 immunotoxins 60 RhuDex ® 60 cytochrome P# #A# 60 Ampligen ® 60 CLORETAZINE TM VNP#M 60 Lamivudine 60 Onconase 60 ALN TTR 60 GW# [003] 60 rHuPH# 60 MVA BN R 60 camptothecin 60 HQK 60 generation purine nucleoside 60 mediated apoptosis 60 nucleotide analogue 60 prodrug 60 immune stimulatory 60 hepatoma 60 ribavirin RBV 60 Abl 60 Amigal 60 Combination therapy 60 chemically modified siRNA 60 TriRima 60 Aptivus ® 60 PKC# 60 EGFR inhibitors 60 capsular polysaccharide 60 IMiDs ® compound 60 myelofibrosis polycythemia vera 60 adipogenic 60 Trastuzumab 60 tanespimycin 60 E#F# 60 HDAC Inhibitor 60 PEG SN# 60 bortezomib Velcade 60 anti leukemic 60 selective agonist 60 constitutively active 60 Annamycin 60 cytokine receptor 60 Pharmacokinetics PK 60 mediated inhibition 60 Interferon alpha 60 C5aR 60 SGLT 60 RNA silencing 60 HDAC6 60 Histone Deacetylase 60 HDAC inhibition 60 IAP inhibitor 60 HBeAg negative 60 immune modulatory 60 interferon lambda 60 Elotuzumab 60 taxanes 60 SGLT2 60 pyrazinamide 60 mitogen activated protein kinase 60 epithelial tumors 60 investigational monoclonal antibody 60 LT NS# 60 N methyl 60 trastuzumab Herceptin R 60 c myc 60 HCV protease inhibitors 60 sorafenib Nexavar 60 glucagon receptor 60 flavopiridol 60 activin 60 Velcade bortezomib 60 peptidomimetic 60 transcriptase inhibitors NNRTIs 60 Fludara 60 mycophenolate mofetil 60 selectively inhibits 60 elvitegravir 60 glucocorticoid receptor 60 paclitaxel Taxol ® 60 lapatinib Tykerb 60 histone deacetylase HDAC inhibitor 60 trastuzumab Herceptin ® 60 serine threonine 60 JAK2 V#F 60 humanized monoclonal 60 Interferon gamma 60 azoles 60 protease inhibitors 60 maturation inhibitor 60 abacavir lamivudine 60 TG# [003] 60 orally dosed 60 NNRTI resistance 60 receptor modulators 60 busulfan 60 Janus Kinase 60 murine monoclonal antibody 60 trimethoprim sulfamethoxazole 60 RAV# 60 alvespimycin 60 combretastatin A4 phosphate CA4P 60 selective inhibitor 60 erlotinib Tarceva 60 delta isoform 60 adenoviral 60 TLK# 60 γ secretase 60 CANCIDAS 60 Sudhir Agrawal D.Phil 60 forodesine 60 cyclic peptide 60 heterologous 60 Protease inhibitors 60 gefitinib Iressa 60 antibody MAb 60 radiolabeled 60 antisense drugs 60 INT# [002] 60 inhibit replication 60 non nucleoside inhibitor 60 somatostatin analogue 60 lentiviral vector 60 poly ADP ribose polymerase 60 immune modulator 60 Guanilib 60 transcriptase inhibitor 60 sorafenib Nexavar ® 60 small molecule inhibitor 60 GAP #B# 60 Talabostat 60 beta lactam antibiotic 60 calcineurin inhibitors 60 survivin 59 splice variants 59 FGFR3 59 Alocrest 59 DermaVir Patch 59 HER2 overexpression 59 selective adenosine 59 p# inhibitor 59 cationic lipid 59 triphosphate 59 T#M 59 reverse transcriptase inhibitor 59 bevacizumab Avastin R 59 vascular disrupting agent 59 glucan 59 CCR5 tropic 59 HspE7 59 gastrin 59 beta interferons 59 entecavir 59 AtuRNAi 59 Squalamine 59 bevirimat 59 tumor necrosis 59 Luteinizing Hormone Releasing Hormone 59 enzyme inhibitor 59 Nilotinib 59 pro angiogenic 59 Pimavanserin 59 Clevudine 59 Sphingomab 59 biologic DMARD 59 antiapoptotic 59 cytotoxic chemotherapy 59 haematopoietic 59 mda 7 59 OHR/AVR# 59 HIV integrase inhibitors 59 Antisense 59 ALK inhibitor 59 PDGFR 59 cathepsin K inhibitor 59 glutamyl 59 amine oxidase 59 druggable 59 eIF4E 59 uricase 59 phospholipid 59 proteolytic cleavage 59 AMN# [001] 59 Nitazoxanide 59 imatinib resistance 59 potentiator 59 chemopreventive agent 59 antithrombotics 59 ErbB3 59 Cytotoxic 59 HuMax EGFr 59 dasatinib Sprycel 59 lamivudine zidovudine 59 immune modulators 59 brostallicin 59 Azacitidine 59 Aplidin 59 substrates inhibitors 59 5 HT3 receptor 59 bendamustine 59 SIRT2 59 sapacitabine 59 NFκB 59 Eg5 59 TELINTRA 59 selective inhibitors 59 INTELENCE 59 hematologic toxicity 59 liposome encapsulated 59 Nanobodies 59 angiotensin receptor blocker ARB 59 Kahalalide F 59 estrogen receptor beta 59 annexin V 59 siRNA mediated 59 IL 1ß 59 potently inhibit 59 Antiviral Activity 59 Cyclosporine 59 virulence genes 59 CCR5 antagonists 59 TNF α 59 pertussis toxin 59 FUS1 59 Immunotherapeutic 59 Epratuzumab 59 HMG CoA reductase inhibitors 59 IMiDs ® 59 subcutaneously administered 59 stem cell pluripotency 59 temsirolimus Torisel ® 59 anticancer agents 59 Pertuzumab 59 HCV replication 59 investigational HCV polymerase 59 hepatocyte 59 erythropoietic 59 PI3K inhibitors 59 gemcitabine Gemzar ® 59 combination antiretroviral therapy 59 PI3K/mTOR 59 leukemia AML 59 single stranded oligonucleotides 59 p# MAPK 59 essential thrombocythemia 59 redox active 59 Valortim R 59 Peg IFN 59 renin inhibitors 59 RNAi therapeutic targeting 59 anti CD# antibodies 59 cytoprotective 59 NEUGENE antisense 59 genotype 1a 59 fluoropyrimidine 59 Akt inhibitor 59 antithrombotic 59 neoplastic 59 DNA methyltransferases 59 BiTE 59 HDAC 59 antisense inhibitors 59 DOXIL 59 antibody fragment 59 beta lactamases 59 proteins peptides 59 androgen receptor AR 59 pediatric acute lymphoblastic 59 Imprime PGG 59 oxidative stress inducer 59 Doxorubicin 59 tenofovir emtricitabine 59 alpha interferon 59 histologies 59 EOquin 59 antiangiogenesis 59 small molecule tyrosine 59 tetramer 59 EGFR TKIs 59 MAXY G# 59 GMX# 59 ritonavir boosted protease inhibitor 59 Tarvacin TM 59 Annexin V 59 small molecule thrombopoietin 59 immunosuppressive 59 oligonucleotide 59 tyrosine kinase inhibitor TKI 59 humanized monoclonal antibodies 59 NS5A 59 DGAT 59 induces apoptosis 59 imipenem 59 AEGR 59 Gemzar ® 59 mutational analysis 59 MGd 59 Vaprisol 59 antagomirs 59 AVI NEUGENE 59 XYOTAX TM 59 LB# [003] 59 anticancer agent 59 DHFR 59 selective orally bioavailable 59 outer membrane proteins 59 Multiple Myeloma MM 59 Cethromycin 59 Doxil ® 59 anionic backbone 59 heparanase 59 p# mitogen activated 59 VEGF inhibitors 59 darunavir ritonavir 59 Atripla combines 59 antifolate 59 Pegasys ® 59 chronic HCV infection 59 efavirenz EFV 59 A2A receptor 59 PEG Interferon lambda 59 replicase 59 siRNA therapeutic 59 dacetuzumab 59 Lenocta 59 constitutively activated 59 relapsed MM 59 RNA antagonists 59 immunoconjugate 59 HCV polymerase 59 HDAC inhibitors 59 ALV# 59 HGS ETR2 59 LHRH antagonists 59 Lenalidomide 59 APTIVUS 59 mesenchymal cell 59 MEK1 59 integrase 59 MDR1 59 EGFR antibodies 59 myeloid 59 acetylcholinesterase AChE 59 TACE 59 clade B 59 nelfinavir Viracept 59 LY# [002] 59 comparator PI r 59 highly immunogenic 59 antimitotic 59 retaspimycin 59 LY# [003] 59 CCR9 antagonist 59 Erlotinib 59 TGF ß 59 angiogenesis inhibitor 59 druggable targets 59 Amrubicin 59 Azedra 59 HTS assay 59 potent anticancer 59 aurora kinase 59 CYP#A# CYP#D# 59 gonadotrophin releasing hormone GnRH 59 HepG2 cells 59 methionine aminopeptidase 59 immunoregulatory 59 Zolinza 59 DNA intercalator 59 GHRH 59 HER1 59 NOD mouse 59 SCCHN 59 partial agonist 59 Fleximer 59 lenalidomide Revlimid R 59 reuptake inhibitors 59 anti mitotic 59 Targretin 59 thiazolides 59 itraconazole 59 TBC# 59 tubulin binding 59 SIRT1 activators 59 lopinavir ritonavir Kaletra 59 enzyme inhibitors 59 cellular cytotoxicity 59 lipid nanoparticles 59 JAK2 59 Beta catenin pathway 59 Atrasentan 59 gemcitabine cisplatin 59 rNAPc2 59 isoform selective 59 TLR3 59 preclinically 59 dasatinib 59 CsA 59 antiangiogenic agent 59 myeloproliferative disorders 59 c MYC 59 demethylating agents 59 TKIs 59 stable nucleic acid 59 selective kinase inhibitor 59 epothilones 59 DOS# 59 cytokine signaling 59 GPx 59 p# activation 59 FUSILEV enhances 59 Omacetaxine mepesuccinate 59 atacicept 59 EZN 59 peripherally acting 59 TELCYTA 59 hepatocellular carcinomas 59 TRO# 59 Vidaza azacitidine 59 visilizumab 59 volociximab 58 BMS# 58 cyclin dependent kinase inhibitor 58 Abiraterone acetate 58 belinostat 58 cancer mCRC 58 systemically administered 58 PEG IFN 58 nephrotoxic 58 glioblastoma multiforme GBM 58 CTA# 58 immunomodulatory therapy 58 IDX# 58 cytotoxicity 58 therapeutically relevant 58 long acting muscarinic 58 HER2 antibody 58 macrolides 58 luteinizing hormone releasing 58 HER2 positive metastatic breast 58 cetuximab Erbitux ® 58 maturation inhibitors 58 temsirolimus 58 vWF 58 platelet inhibitor 58 PDGF B 58 panobinostat 58 efavirenz emtricitabine 58 administered subcutaneously 58 Amplimexon 58 sitaxsentan 58 CCR9 58 HCV nucleoside 58 monoclonal antibody mAb 58 Ganciclovir 58 viral kinetics 58 piperacillin tazobactam 58 fusion proteins 58 Myelodysplastic Syndrome MDS 58 biologic therapeutics 58 potent topoisomerase II 58 relapsed acute myelogenous 58 palifosfamide 58 RezularTM 58 PS# [001] 58 anti secretory 58 torezolid 58 nicotinic alpha 7 58 IMPDH 58 docetaxel chemotherapy 58 IFN gamma 58 M1 muscarinic 58 ATL# [002] 58 antineoplastic agents 58 CDDO Im 58 otelixizumab 58 integrase inhibitors 58 ADP receptor antagonist 58 metastatic RCC 58 uric acid lowering 58 Letairis ambrisentan 58 lamivudine 58 metformin sulfonylurea 58 faropenem 58 Zalypsis 58 TREANDA 58 inhibitor RG# 58 ansamycin 58 fosamprenavir 58 QbG# 58 LPV r 58 insulin sensitizer 58 vinblastine 58 synthetic peptide 58 Oncaspar 58 SARMs 58 Dalbavancin 58 intravenously administered 58 antigen sparing 58 antiproliferative effects 58 Bicifadine 58 lumefantrine 58 Tipranavir 58 voreloxin 58 oritavancin 58 mTOR inhibitor 58 hematological malignancies 58 novel orally bioavailable 58 NS5B polymerase 58 TMEM#B 58 Curaxins 58 interleukin IL -# 58 ALN PCS 58 targeted radiotherapeutic 58 small molecule chemotherapeutic 58 Bcr Abl mutations 58 Panzem R 58 racemic mixture 58 myeloproliferative diseases 58 phase IIb clinical

Back to home page